[go: up one dir, main page]

DE69943084D1 - MUCOADHESIVE COMPOSITION FOR THE ADMINISTRATION OF BIOLOGICALLY ACTIVE SUBSTANCES IN ANIMAL TISSUE - Google Patents

MUCOADHESIVE COMPOSITION FOR THE ADMINISTRATION OF BIOLOGICALLY ACTIVE SUBSTANCES IN ANIMAL TISSUE

Info

Publication number
DE69943084D1
DE69943084D1 DE69943084T DE69943084T DE69943084D1 DE 69943084 D1 DE69943084 D1 DE 69943084D1 DE 69943084 T DE69943084 T DE 69943084T DE 69943084 T DE69943084 T DE 69943084T DE 69943084 D1 DE69943084 D1 DE 69943084D1
Authority
DE
Germany
Prior art keywords
administration
biologically active
active substances
animal tissue
mucoadhesive composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69943084T
Other languages
German (de)
Inventor
Kishore R Shah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Polytherapeutics Inc
Original Assignee
Polytherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22130640&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69943084(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polytherapeutics Inc filed Critical Polytherapeutics Inc
Application granted granted Critical
Publication of DE69943084D1 publication Critical patent/DE69943084D1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

This invention pertains to mucoadhesive compositions for the delivery of pharmacologically active agents, and to polymeric formulations that allow for a prolonged, sustained release of the active agents. More specically the invention pertains to compositions for the delivery of drugs to mucosal tissue, said composition comprising a drug or a plurality of drugs to be delivered and a thermoplastic graft copolymer, said graft copolymer being the reaction product of a polystyrene macromonomer having an ethylenically unsaturated functional group, and at least one acidic hydrophilic monomer having an ethylenically unsaturated functional group.
DE69943084T 1998-05-12 1999-05-11 MUCOADHESIVE COMPOSITION FOR THE ADMINISTRATION OF BIOLOGICALLY ACTIVE SUBSTANCES IN ANIMAL TISSUE Expired - Lifetime DE69943084D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/076,216 US5942243A (en) 1996-11-12 1998-05-12 Mucoadhesive compositions for administration of biologically active agents to animal tissue
PCT/US1999/010218 WO1999058110A1 (en) 1998-05-12 1999-05-11 Mucoadhesive compositions for administration of biologically active agents to animal tissue

Publications (1)

Publication Number Publication Date
DE69943084D1 true DE69943084D1 (en) 2011-02-10

Family

ID=22130640

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69943084T Expired - Lifetime DE69943084D1 (en) 1998-05-12 1999-05-11 MUCOADHESIVE COMPOSITION FOR THE ADMINISTRATION OF BIOLOGICALLY ACTIVE SUBSTANCES IN ANIMAL TISSUE

Country Status (7)

Country Link
US (1) US5942243A (en)
EP (1) EP1077678B1 (en)
JP (1) JP2002514589A (en)
AT (1) ATE493114T1 (en)
CA (1) CA2331350A1 (en)
DE (1) DE69943084D1 (en)
WO (1) WO1999058110A1 (en)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010057582A (en) * 1999-12-23 2001-07-04 미쉘 지. 멘지니 Method of preparing a water soluble film
US20020013331A1 (en) 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
US6599973B1 (en) * 2000-09-27 2003-07-29 E. I. Du Pont De Nemours And Company Aqueous graft copolymer pigment dispersants
DE10107659B4 (en) * 2001-02-19 2008-03-13 Lts Lohmann Therapie-Systeme Ag Mucoadhesive disintegratable drug preparation for drug administration in veterinary and human medicine
DE60325353D1 (en) * 2002-05-21 2009-01-29 Abbott Lab TREATMENT OF MUCOSITIS
ES2237298B1 (en) 2003-07-16 2006-11-01 Italfarmaco, S.A. SEMISOLID MUCOADHESIVE FORMULATIONS.
US7569223B2 (en) * 2004-03-22 2009-08-04 The Rockefeller University Phage-associated lytic enzymes for treatment of Streptococcus pneumoniae and related conditions
US7771740B2 (en) * 2004-07-19 2010-08-10 Boston Scientific Scimed, Inc. Medical devices containing copolymers with graft copolymer endblocks for drug delivery
EP2446894A3 (en) 2004-10-27 2013-02-20 University Of Denver Adrenocorticotropic hormone analogs and related methods
US7402624B2 (en) * 2004-11-08 2008-07-22 E.I. Du Pont De Nemours & Company Graft copolymers with segmented arms and their preparation and use
EP1877446A1 (en) * 2005-03-02 2008-01-16 Polyrizon Ltd. Method for removal of toxins from mucosal membranes
US20060271262A1 (en) * 2005-05-24 2006-11-30 Mclain Harry P Iii Wireless agricultural network
WO2008018854A2 (en) * 2005-06-06 2008-02-14 The Rockefeller University Bactiophage lysins for bacillus anthracis
US7582291B2 (en) * 2005-06-30 2009-09-01 The Rockefeller University Bacteriophage lysins for Enterococcus faecalis, Enterococcus faecium and other bacteria
ATE491026T1 (en) 2005-08-24 2010-12-15 Univ Rockefeller PLY-GBS-LYSINE MUTANTS
US20100028447A1 (en) 2007-01-22 2010-02-04 Targacept, Inc. Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs
ES2310968B1 (en) * 2007-06-25 2010-02-08 Italfarmaco, S.A. USE OF ESTRIOL IN LOW DOSE.
MX341715B (en) * 2007-07-19 2016-08-23 Allexcel Inc Self-assembling amphiphilic polymers as anticancer agents.
CN101327187B (en) * 2007-12-27 2010-11-24 刘德胜 Nonoxynol nonylphenoxy-polyethoxyethanol suppositorium and preparation method thereof
KR101683042B1 (en) 2008-04-04 2016-12-06 포사이트 비젼4, 인크. Therapeutic device for pain management and vision
ES2344673B1 (en) * 2008-08-07 2011-05-03 Italfarmaco, S.A. USE OF ESTRIOL IN THE PREPARATION OF A PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF VAGINAL ATROPHY IN WOMEN WITH RISK OF POTOLOGIATUMORAL.
ES2344675B1 (en) 2008-12-19 2011-04-28 Italfarmaco, S.A. USE OF ESTRIOL IN THE PREPARATION OF A PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF VAGINAL ATROPHY IN WOMEN WITH RISK OF VARIUM VARCOLOGY.
US20110033515A1 (en) * 2009-08-04 2011-02-10 Rst Implanted Cell Technology Tissue contacting material
WO2011050327A1 (en) 2009-10-23 2011-04-28 Forsight Labs Llc Corneal denervation for treatment of ocular pain
WO2011050365A1 (en) 2009-10-23 2011-04-28 Forsight Labs, Llc Conformable therapeutic shield for vision and pain
WO2012087749A1 (en) * 2010-12-20 2012-06-28 Polytherapeutics, Inc. Composition for transdermal administration of non-steroidal anti-inflammatory drug
DK2699253T3 (en) 2011-04-21 2018-07-16 Univ Rockefeller STREPTOCOCCUS BACTERYPHAGIC LYSINES FOR THE DETECTION AND TREATMENT OF GRAM POSITIVE BACTERIES
WO2014210186A2 (en) 2013-06-26 2014-12-31 Nexisvision, Inc. Contact lenses for refractive correction
US12044905B2 (en) 2011-04-28 2024-07-23 Journey1 Inc Contact lenses for refractive correction
US9279118B2 (en) 2011-10-05 2016-03-08 The Rockefeller University Dimeric bacteriophage lysins
BR112014012444B1 (en) 2011-11-23 2021-12-14 Therapeuticsmd, Inc A PHARMACEUTICAL COMPOSITION COMPRISING SOLUBILIZED ESTRADIOL, PROGESTERONE AND A SOLUBILIZING AGENT, AND USES THEREOF TO TREAT A MENOPAUSE-RELATED SYMPTOM IN A WOMAN
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CA2947767A1 (en) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
WO2019126670A1 (en) 2017-12-22 2019-06-27 The Rockefeller University Recombinant pseudomonas aeruginosa lysins
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
WO2025082731A1 (en) * 2023-10-20 2025-04-24 Mosanna Therapeutics Ag Intranasal formulations for treating obstructive sleep apnea

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
GB1432783A (en) * 1972-04-14 1976-04-22 Cpc International Inc Macromolecular monomers
EP0501523B1 (en) * 1983-11-14 1997-04-09 Columbia Laboratories, Inc. Bioadhesive compositions
US5234957A (en) * 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5053461A (en) * 1988-08-31 1991-10-01 Mitsubishi Rayon Co., Ltd. Preparation method of comb copolymer, acrylic comb copolymer, and impact resistant resin composition
JPH02258718A (en) * 1989-03-31 1990-10-19 Nippon Kayaku Co Ltd Pasty base and pharmaceutical
GB2235459B (en) * 1989-08-09 1993-06-23 Toa Gosei Chem Ind Process for producing an aqueous resin dispersion
US4994322A (en) * 1989-09-18 1991-02-19 Minnesota Mining And Manufacturing Pressure-sensitive adhesive comprising hollow tacky microspheres and macromonomer-containing binder copolymer
JP2901708B2 (en) * 1990-06-14 1999-06-07 リンテック株式会社 Mucoadhesive
US5104952A (en) * 1990-11-15 1992-04-14 Minnesota Mining And Manufacturing Company Macromolecular monomers from living polymers
US5352516A (en) * 1992-01-31 1994-10-04 Adhesives Research, Inc. Water-inactivatable pressure sensitive adhesive
US5417983A (en) * 1992-02-19 1995-05-23 Sagami Chemical Research Center Drug release controlling material responsive to changes in temperature
TW359614B (en) * 1993-08-31 1999-06-01 Takeda Chemical Industries Ltd Composition containing benzimidazole compounds for rectal administration
US5527271A (en) * 1994-03-30 1996-06-18 Bristol-Myers Squibb Co. Thermoplastic hydrogel impregnated composite material
US5667492A (en) * 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
US5573778A (en) * 1995-03-17 1996-11-12 Adhesives Research, Inc. Drug flux enhancer-tolerant pressure sensitive adhesive composition
US5770627A (en) * 1995-08-16 1998-06-23 University Of Washington Hydrophobically-modified bioadhesive polyelectrolytes and methods relating thereto
US5814329A (en) * 1996-11-12 1998-09-29 Polytherapeutics, Inc. Hydrophilic polystyrene graft copolymer vehicle for intravaginal administration of pharmacologically active agents

Also Published As

Publication number Publication date
ATE493114T1 (en) 2011-01-15
WO1999058110A1 (en) 1999-11-18
US5942243A (en) 1999-08-24
EP1077678A4 (en) 2009-03-18
EP1077678A1 (en) 2001-02-28
EP1077678B1 (en) 2010-12-29
CA2331350A1 (en) 1999-11-18
JP2002514589A (en) 2002-05-21

Similar Documents

Publication Publication Date Title
ATE493114T1 (en) MUCOADHESIVE COMPOSITION FOR ADMINISTRATION OF BIOLOGICALLY ACTIVE SUBSTANCES IN ANIMAL TISSUE
DE69909519D1 (en) BIODEGRADABLE PH / THERMOSENSITIVE HYDROGELS FOR THE DELAYED RELEASE OF BIOLOGICALLY ACTIVE SUBSTANCES
IT1318539B1 (en) PROLONGED RELEASE PHARMACEUTICAL COMPOSITIONS FOR THE PARENTERAL ADMINISTRATION OF BIOLOGICALLY HYDROPHILE SUBSTANCES
TR200200562T2 (en) Pharmaceutical compositions for oral release that can be secreted in the body in a controlled manner and prevent unpleasant taste
DE69620182D1 (en) POLYMER LAMELLAR SUBSTRATE PARTICLES FOR THE ADMINISTRATION OF MEDICINAL PRODUCTS
WO2002078601A3 (en) Drug release from polymer matrices through mechanical stimulation
ATE405251T1 (en) COMPOSITIONS FOR DELAYED RELEASE OF HYDROPHOBIC MEDICINAL PRODUCTS AND METHOD FOR THE PRODUCTION THEREOF
BR0107942A (en) Slow Release Protein Polymers
ATE302616T1 (en) MEDICINAL COMPOSITIONS FOR ORAL APPLICATION WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS
DE3850823D1 (en) Drug release system and method of manufacture.
WO2003044076A8 (en) Bioerodible poly(ortho esters) containing amine groups, and block copolymers containing them
WO2001091725A3 (en) Biologically useful polyphosphates
BR9808703A (en) Composition that provides relatively slow-dissolving water-soluble medication and unique uses
SE9704401D0 (en) Matrix pellets for greasy, oily or sticky drug substances
ATE513541T1 (en) PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION OF CALCITONIN
PT1521572E (en) Bioerodible film for ophthalmic drug delivery
ATE438389T1 (en) MIXING SYSTEM FOR PROVIDING SOLUBILITY OF PHARMACEUTICAL ACTIVE INGREDIENTS IN POLYMER MATRICES
DE69940635D1 (en) COPOLYMER COMPOSITIONS FOR ORAL ADMINISTRATION
DE602004009552D1 (en) ORAL DELIVERY SYSTEM WITH AN ANTIBACTERIAL AND ANTI-INFLAMMATORY AGENT
PT975334E (en) BIODEGRADABLE MICROPARTICLES FOR THE SUSTAINED LIBERATION OF THERAPEUTIC PHARMACOS
EP1539109A4 (en) COPOLYMER MICEL COMPOSITION WITH IMPROVED CAPACITY CAPACITY CAPACITY CAPACITY CAPACITY INCREASE AND PROLONGED DRUG RELEASE CAPACITY
IL154731A0 (en) Ion-strength independent sustained release pharmaceutical formulation
WO2002030399A3 (en) Polymer controlled delivery of a therapeutic agent
SE9603480D0 (en) Dosage form for hard soluble drugs
WO2005107702A3 (en) Sustained release, mucoadhesive vaginal pharmaceutical compositions